T1	CHEM 63 72	nivolumab
#1	AnnotatorNotes T1	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T2	CHEM 75 85	ipilimumab
#2	AnnotatorNotes T2	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	PROC 92 117	prevención de la recidiva
T4	DISO 121 129	melanoma
#3	AnnotatorNotes T4	C0025202; melanoma; Neoplastic Process
T5	PROC 163 181	resección completa
#4	AnnotatorNotes T5	C0015250; Complete excision; Therapeutic or Preventive Procedure
T6	PROC 203 244	Estudio fase 3, aleatorizado, doble ciego
T7	PROC 248 261	inmunoterapia
#5	AnnotatorNotes T7	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T8	CHEM 280 289	Nivolumab
#6	AnnotatorNotes T8	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	CHEM 297 307	Ipilimumab
#7	AnnotatorNotes T9	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T10	DISO 324 332	melanoma
#8	AnnotatorNotes T10	C0025202; melanoma; Neoplastic Process
T11	PROC 404 422	resección completa
#9	AnnotatorNotes T11	C0015250; Complete excision; Therapeutic or Preventive Procedure
T12	ANAT 469 475	sangre
#10	AnnotatorNotes T12	C0005767; Blood; Body Substance
T13	PROC 499 526	estudios de farmacogenética
#11	AnnotatorNotes T13	C3494710; Pharmacogenetic consultation; Health Care Activity (?)
T14	DISO 615 623	melanoma
#12	AnnotatorNotes T14	C0025202; melanoma; Neoplastic Process
T15	DISO 719 727	melanoma
#13	AnnotatorNotes T15	C0025202; melanoma; Neoplastic Process
T16	PROC 755 773	resección completa
#14	AnnotatorNotes T16	C0015250; Complete excision; Therapeutic or Preventive Procedure
T17	DISO 953 961	Melanoma
#15	AnnotatorNotes T17	C0025202; melanoma; Neoplastic Process
T18	PROC 989 996	cirugía
#16	AnnotatorNotes T18	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T19	PROC 1035 1049	aleatorización
#17	AnnotatorNotes T19	C0034656; Randomization; Research Activity
T20	PROC 1096 1114	resección completa
#18	AnnotatorNotes T20	C0015250; Complete excision; Therapeutic or Preventive Procedure
T21	PROC 1121 1147	tratamiento anti canceroso
T22	DISO 1138 1147	canceroso
#19	AnnotatorNotes T22	C0006826; Malignant Neoplasms; Neoplastic Process
T23	ANAT 1211 1217	hígado
#20	AnnotatorNotes T23	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T24	ANAT 1220 1225	riñón
#21	AnnotatorNotes T24	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T25	DISO 1254 1277	Melanoma ocular o uveal
T26	ANAT 1272 1277	uveal
#22	AnnotatorNotes T26	C0042160; Uvea; Body Part, Organ, or Organ Component
T27	DISO 1293 1303	meningitis
#23	AnnotatorNotes T27	C0025289; Meningitis; Disease or Syndrome
T28	DISO 1306 1320	carcinomatosis
#24	AnnotatorNotes T28	C0205699; Carcinomatosis; Neoplastic Process
T29	DISO 1337 1363	enfermedad autoinmunitaria
#25	AnnotatorNotes T29	C0004364; Autoimmune Diseases; Disease or Syndrome
T30	DISO 1396 1415	neoplasias malignas
#26	AnnotatorNotes T30	C0006826; Malignant Neoplasms; Neoplastic Process
T31	DISO 1438 1446	melanoma
#27	AnnotatorNotes T31	C0025202; melanoma; Neoplastic Process
T32	ANAT 1200 1209	sanguinea
#28	AnnotatorNotes T32	C0005767; Blood; Body Substance
T33	PROC 1553 1573	Tratamiento dirigido
#29	AnnotatorNotes T33	C2985566; Targeted Therapy; Therapeutic or Preventive Procedure
T34	DISO 1583 1591	melanoma
#30	AnnotatorNotes T34	C0025202; melanoma; Neoplastic Process
T35	PROC 1645 1649	Test
#31	AnnotatorNotes T35	C0022885; Laboratory Procedures; Laboratory Procedure
T36	DISO 1662 1673	Hepatitis B
#32	AnnotatorNotes T36	C0019163; Hepatitis B; Disease or Syndrome
T37	DISO 1675 1686	Hepatitis C
#33	AnnotatorNotes T37	C0019196; Hepatitis C; Disease or Syndrome
T38	PROC 457 475	muestras de sangre
#34	AnnotatorNotes T38	C0005834; Collection of blood specimen for laboratory procedure; Diagnostic Procedure | C1277698; Blood sample taken; Laboratory Procedure
T39	PROC 624 646	completamente resecado
#35	AnnotatorNotes T39	C0015250; Complete excision; Therapeutic or Preventive Procedure
T40	PROC 962 984	completamente resecado
T41	ANAT 1263 1269	ocular
#36	AnnotatorNotes T41	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T42	PROC 1592 1600	resecado
#37	AnnotatorNotes T42	C0728940; Excision; Therapeutic or Preventive Procedure
T43	PROC 1633 1640	cirugía
#38	AnnotatorNotes T43	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T44	DISO 1689 1692	VIH
#39	AnnotatorNotes T44	C0458074; Human immunodeficiency virus (HIV) status; Finding
T45	Date 12 16	2014
T47	LIVB 312 319	sujetos
#40	AnnotatorNotes T47	C0681850; Study Subject; Group
T50	Date 559 581	3 de diciembre de 2014
T51	LIVB 603 610	Sujetos
#41	AnnotatorNotes T51	C0681850; Study Subject; Group
T53	LIVB 707 714	sujetos
#42	AnnotatorNotes T53	C0681850; Study Subject; Group
T56	LIVB 831 838	Hombres
#43	AnnotatorNotes T56	C0025266; Male population group; Population Group
T57	LIVB 841 848	mujeres
#44	AnnotatorNotes T57	C0043210; Woman; Population Group
T58	Age 852 868	al menos 15 años
T59	LIVB 902 909	sujetos
#45	AnnotatorNotes T59	C0681850; Study Subject; Group
T60	Age 914 931	18 años o mayores
T63	Duration 1017 1031	las 12 semanas
T65	Neg_cue 1117 1120	Sin
T66	PHYS 1188 1209	circulación sanguinea
#46	AnnotatorNotes T66	C0005775; Blood Circulation; Physiologic Function
T67	Neg_cue 1367 1377	Se excluye
T68	LIVB 1384 1391	sujetos
#47	AnnotatorNotes T68	C0681850; Study Subject; Group
T70	Duration 1500 1515	al menos 3 años
T46	DISO 109 117	recidiva
#48	AnnotatorNotes T46	C2825055; Recurrence (disease attribute); Pathologic Function
T48	DISO 390 398	recidiva
#49	AnnotatorNotes T48	C2825055; Recurrence (disease attribute); Pathologic Function
T49	Spec_cue 380 389	riesgo de
T52	Spec_cue 663 672	riesgo de
T54	DISO 673 681	recidiva
#50	AnnotatorNotes T54	C2825055; Recurrence (disease attribute); Pathologic Function
T55	Spec_cue 784 793	riesgo de
T61	DISO 794 802	recidiva
#51	AnnotatorNotes T61	C2825055; Recurrence (disease attribute); Pathologic Function
T62	PROC 939 949	reclutarse
#52	AnnotatorNotes T62	C0242800; Patient Recruitment; Research Activity
A1	Assertion T21 Negated
A2	Assertion T68 Negated
A3	Assertion T30 Negated
A4	Assertion T48 Speculated
A5	Assertion T54 Speculated
A6	Assertion T61 Speculated
A7	Status T21 History_of
A8	Status T28 History_of
A9	Status T27 History_of
A10	Status T29 History_of
A11	Status T30 History_of
A12	Status T31 History_of
A13	Status T44 History_of
A14	Status T37 History_of
A15	Status T36 History_of
#53	AnnotatorNotes T3	C0679867; Relapse Prevention; Therapeutic or Preventive Procedure
#54	AnnotatorNotes T6	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#55	AnnotatorNotes T25	C0220633; Uveal melanoma; Neoplastic Process + C0558356; Malignant melanoma of eye; Neoplastic Process 
T64	Observation 1482 1499	remisión completa
#56	AnnotatorNotes T64	C0677874; In complete remission; Finding
R1	Negation Arg1:T67 Arg2:T68	
R2	Negation Arg1:T67 Arg2:T30	
R3	Experiences Arg1:T68 Arg2:T31	
R4	Before Arg1:T30 Arg2:T31	
R5	Experiences Arg1:T68 Arg2:T64	
R6	Before Arg1:T30 Arg2:T64	
R7	Has_Duration_or_Interval Arg1:T64 Arg2:T70	
T69	PROC 1542 1549	estudio
#57	AnnotatorNotes T69	C0008976; Clinical Trials; Research Activity
R8	Before Arg1:T64 Arg2:T69	
R9	Experiences Arg1:T68 Arg2:T30	
R10	After Arg1:T33 Arg2:T43	
T71	Result_or_Value 1650 1658	positivo
#58	AnnotatorNotes T71	C1446409; Positive; Finding
R14	Has_Result_or_Value Arg1:T35 Arg2:T71	
R15	Used_for Arg1:T1 Arg2:T3	
R16	Used_for Arg1:T2 Arg2:T3	
R17	Before Arg1:T3 Arg2:T46	
R18	Before Arg1:T4 Arg2:T46	
T72	Quantifier_or_Qualifier 130 157	estadio IIIb/c o estadio IV
R19	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T72	
R20	After Arg1:T46 Arg2:T5	
R21	After Arg1:T1 Arg2:T5	
R22	After Arg1:T2 Arg2:T5	
R23	Combined_with Arg1:T7 Arg2:T8	
R24	Combined_with Arg1:T7 Arg2:T9	
R25	Experiences Arg1:T47 Arg2:T7	
R26	Experiences Arg1:T47 Arg2:T10	
T73	Quantifier_or_Qualifier 333 360	estadio IIIb/c o estadio IV
R27	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T73	
T74	Observation 375 389	alto riesgo de
#59	AnnotatorNotes T74	C0332167; High risk of; Finding
R28	Before Arg1:T74 Arg2:T48	
R29	Speculation Arg1:T49 Arg2:T48	
R30	Experiences Arg1:T47 Arg2:T74	
R31	Before Arg1:T10 Arg2:T48	
R32	After Arg1:T48 Arg2:T11	
R33	After Arg1:T74 Arg2:T11	
R34	After Arg1:T7 Arg2:T11	
R35	After Arg1:T8 Arg2:T11	
R36	After Arg1:T9 Arg2:T11	
R37	Experiences Arg1:T47 Arg2:T11	
R38	Before Arg1:T38 Arg2:T13	
R39	Experiences Arg1:T51 Arg2:T14	
R41	Experiences Arg1:T51 Arg2:T39	
R42	Speculation Arg1:T52 Arg2:T54	
R43	Speculation Arg1:T55 Arg2:T61	
T76	Observation 658 672	alto riesgo de
#61	AnnotatorNotes T76	C0332167; High risk of; Finding
T77	Observation 779 793	alto riesgo de
#62	AnnotatorNotes T77	C0332167; High risk of; Finding
R44	Before Arg1:T77 Arg2:T61	
R45	Before Arg1:T76 Arg2:T54	
R46	Overlap Arg1:T14 Arg2:T76	
R47	Before Arg1:T14 Arg2:T54	
R48	Experiences Arg1:T53 Arg2:T15	
T78	Quantifier_or_Qualifier 731 750	estadio IIIb/c y IV
R49	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T78	
R50	Experiences Arg1:T53 Arg2:T16	
R40	Experiences Arg1:T51 Arg2:T76	
R51	Before Arg1:T39 Arg2:T54	
R52	Before Arg1:T16 Arg2:T61	
R53	Overlap Arg1:T15 Arg2:T77	
R54	Experiences Arg1:T53 Arg2:T77	
R55	Experiences Arg1:T53 Arg2:T61	
R56	Has_Age Arg1:T56 Arg2:T58	
R57	Has_Age Arg1:T57 Arg2:T58	
R58	Has_Age Arg1:T59 Arg2:T60	
R59	Has_Age Arg1:T56 Arg2:T60	
R60	Has_Age Arg1:T57 Arg2:T60	
#60	AnnotatorNotes T40	C0015250; Complete excision; Therapeutic or Preventive Procedure
R61	Overlap Arg1:T40 Arg2:T19	
R62	Overlap Arg1:T18 Arg2:T19	
R63	Has_Duration_or_Interval Arg1:T19 Arg2:T63	
T75	Quantifier_or_Qualifier 1053 1083	Estadio IIIb/IIIc o estadío IV
R64	Before Arg1:T75 Arg2:T20	
R65	Negation Arg1:T65 Arg2:T21	
T79	Observation 1158 1225	Funcionamiento adecuado de la circulación sanguinea, hígado y riñón
#63	AnnotatorNotes T79	C3810095; Normal hematologic parameters; Finding (?) + C1848676; Normal liver function; Finding + C0232805; Normal renal function; Finding
R66	Location_of Arg1:T23 Arg2:T79	
R67	Location_of Arg1:T24 Arg2:T79	
R68	Location_of Arg1:T41 Arg2:T25	
R69	Location_of Arg1:T26 Arg2:T25	
R70	After Arg1:T33 Arg2:T42	
R71	Causes Arg1:T36 Arg2:T71	
R72	Causes Arg1:T37 Arg2:T71	
R73	Causes Arg1:T44 Arg2:T71	
R74	Experiences Arg1:T51 Arg2:T54	
#64	AnnotatorNotes T21	C0920425; cancer treatment; Therapeutic or Preventive Procedure
R75	Experiences Arg1:T56 Arg2:T62	
R76	Experiences Arg1:T57 Arg2:T62	
R11	Experiences Arg1:T47 Arg2:T48	
A16	Experiencer T68 Patient
A17	Assertion T64 Hypothetical
A18	Assertion T70 Hypothetical
A19	Experiencer T47 Patient
A20	Experiencer T51 Patient
A21	Experiencer T53 Patient
A22	Experiencer T57 Patient
A23	Experiencer T56 Patient
A24	Experiencer T59 Patient
